| Heading: |
Peripheral Arterial Disease: Health Services |
| Question ID: |
1782104 |
| UIN: |
36316 |
| House: |
Commons |
| Date tabled: |
2025-03-06 |
| Asking Member ID: |
5335 |
| Asking Member display name: |
Jess Brown-Fuller
|
| Asking Member handle: |
JessBrownFuller
|
| Asking Member Twitter reference: |
@JessBrownFuller
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of current diagnosis and treatment pathways for patients with peripheral arterial disease. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is working with NHS England to take several steps to improve diagnosis, care and treatment for patients with peripheral arterial disease. For example, in 2022, NHS England commissioned a two-year Commissioning for Quality and Innovation (CQ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |